Dexcom launches Stelo, its first over-the-counter continuous glucose monitor

Dexcom launches Stelo, its first over-the-counter continuous glucose monitor

Zoom In IconArrows pointing outwards User wearing Stelo CGM from Dexcom. Courtesy of Dexcom Dexcom on Monday announced its new over-the-counter continuous glucose monitor Stelo is officially available for purchase in the U.S. Glucose is a type of sugar people receive from food, and it’s the body’s main source of energy. Continuous glucose monitors, or … Read more

New Covid shots from Pfizer, Moderna, what to know

New Covid shots from Pfizer, Moderna, what to know

Moderna Covid-19 Vaccine mRNA 2024-2025 formula. Courtesy: Moderna A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. It’s that time of the year again. A new round of Covid shots is on its way to Americans.  … Read more

FDA authorizes Novavax Covid vaccine targeting JN.1

FDA authorizes Novavax Covid vaccine targeting JN.1

A vial labelled “Novavax V COVID-19 Vaccine” is seen in this illustration taken January 16, 2022.  Dado Ruvic | Reuters The Food and Drug Administration authorized Novavax‘s updated protein-based Covid vaccine for emergency use in people ages 12 and up on Friday, paving the way for the shot to compete with Pfizer and Moderna‘s jabs … Read more

We’re taking a nearly 300% profit on a hot drug stock

We’re taking a nearly 300% profit on a hot drug stock

Shortly after the opening bell, we’ll be selling 10 shares of Eli Lilly at roughly $958 each. Following Monday’s trade, Jim Cramer’s Charitable Trust will own 100 shares of LLY, decreasing its weighting to 2.85% from about 3.13%. Now that we are no longer restricted, we are selling some Eli Lilly shares. We downgraded Lilly … Read more

Abbott launches its first over-the-counter continuous glucose monitor in the U.S.

Abbott launches its first over-the-counter continuous glucose monitor in the U.S.

A man wearing Abbott’s Lingo biosensor. Courtesy of Abbott Abbott Laboratories announced Thursday its over-the-counter continuous glucose monitor Lingo is available in the U.S. starting at $49.  Lingo is part of an emerging class of consumer-friendly biosensors that people can use to learn how their bodies respond to food, exercise, sleep and stress. These devices, … Read more